.infobox .infobox-protein
{
float: right;
width: 300px;
padding: 10px;
background: #f8f9fa;
border: 1px solid #ddd;
border-radius: 4px;
margin: 10px;
}
.infobox .infobox-protein th
{
background: #28a745;
color: white;
padding: 8px;
}
.infobox .infobox-protein td
{
padding: 6px;
}
PLA2G6 (Group VI Calcium-Independent Phospholipase A2) is a member of the phospholipase A2 family that plays important roles in membrane lipid metabolism and cellular signaling. This page covers the structure, function, and disease relevance of PLA2G6 in neurodegenerative processes.
PLA2G6 (iPLA2-VIA) is a calcium-independent phospholipase A2 enzyme that hydrolyzes the sn-2 position of phospholipids, releasing free fatty acids and lysophospholipids. Unlike cytosolic PLA2 enzymes, it does not require calcium for activity. The enzyme is primarily localized to mitochondria and is involved in membrane remodeling, lipid signaling, and mitochondrial function.
PLA2G6 contains ankyrin repeat domains at the N-terminus and a catalytic lipase domain at the C-terminus. The ankyrin repeats may mediate protein-protein interactions. The enzyme does not require calcium for activity, unlike cytosolic PLA2 enzymes.
PLA2G6 (iPLA2-VIA) is a calcium-independent phospholipase A2 that hydrolyzes the sn-2 position of phospholipids, releasing free fatty acids and lysophospholipids. It is involved in membrane remodeling, lipid signaling, and mitochondrial function. PLA2G6 generates lipid second messengers that regulate various cellular processes.
PLA2G6 mutations cause infantile neuroaxonal dystrophy (INAD) and atypical parkinsonism (PARK14). These disorders feature iron accumulation in the brain (NBIA). PLA2G6 deficiency leads to mitochondrial dysfunction, oxidative stress, and impaired membrane remodeling in neurons.
No specific therapies exist for PLA2G6-related disorders. Antioxidants and mitochondrial protectants are being explored. Gene replacement therapy is being developed for INAD. Lipid-based therapies to compensate for altered phospholipid metabolism are under investigation.
The study of Pla2G6 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.